APHB APHB
— —
Day range unavailable
52-week range unavailable
News
benzinga.com 52 Biggest Movers From Yesterday 
benzinga.com 41 Stocks Moving In Monday's Mid-Day Session 
businesswire.com AmpliPhi Biosciences and C3J Therapeutics Agree to Merge SAN DIEGO & LOS ANGELES--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (“AmpliPhi”) (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of precisely targeted…- benzinga.com Stocks Which Set New 52-Week Low Last Trading Session, Fri., Dec. 14, 2018
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Thurs., Dec. 13, 2018 
benzinga.com Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 28, 2018 - benzinga.com Stocks Which Set New 52-Week Low Yesterday, Tues., Nov. 20, 2018
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 29th
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 23rd
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 11th 
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 10th 
benzinga.com Stocks Which Set New 52-Week Low Yesterday, October 9th 
businesswire.com AmpliPhi Biosciences to Hold 2018 First Quarter and Business Update
Conference Call on May 15 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections…
businesswire.com AmpliPhi Biosciences Announces Positive Interim Results for
Single-Patient Expanded Access Program Utilizing AB-SA01 and AB-PA01 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for…
businesswire.com AmpliPhi Biosciences to Hold 2017 Third Quarter and Business Update
Conference Call on November 14 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections…- benzinga.com Benzinga's Top Upgrades, Downgrades For August 28, 2017
businesswire.com AmpliPhi Biosciences to Hold 2017 Second Quarter and Business Update
Conference Call on August 14 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of therapies to treat drug-resistant infections using bacteriophage-based technology,…
businesswire.com AmpliPhi Biosciences to Hold Business Update Conference Call on May 15 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections,…
businesswire.com CORRECTING and REPLACING AmpliPhi Biosciences Reports
Favorable Final Results From Phase 1 Trial of AB-SA01 SAN DIEGO--(BUSINESS WIRE)--Reissuing release to correct ticker symbol for searching purposes. The corrected release reads: AMPLIPHI BIOSCIENCES REPORTS FAVORABLE FINAL RESULTS FROM PHASE 1 TRIAL OF…
businesswire.com AmpliPhi Biosciences Confirms Clinical Trial Progress and Announces
Upcoming Conference Call to Provide Corporate Update and Discuss Second
Quarter 2016 Financial Results on August 15, 2016 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections,…
businesswire.com AmpliPhi Biosciences to Host Conference Call and Webcast Discussion
of First Quarter 2016 Financial Results on May 13, 2016 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections,…
businesswire.com AmpliPhi Biosciences to Host Full-Year 2015 Financial Results
Conference Call and Webcast on March 30, 2016 SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSEMKT:APHB), a global leader in developing bacteriophage-based antibacterial therapies to treat drug-resistant infections, today…
businesswire.com AmpliPhi BioSciences to Host Shareholder Update Conference Call RICHMOND, Va. & LJUBLJANA, Slovenia & SYDNEY--(BUSINESS WIRE)--AmpliPhi BioSciences Corporation (OTCQB:APHB) (“AmpliPhi”), the leader in the discovery and development of bacteriophage based therapies…